Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease

被引:0
|
作者
Naoyuki Fujimori [1 ]
Takeji Umemura [1 ]
Takefumi Kimura [1 ]
Naoki Tanaka [2 ,3 ]
Ayumi Sugiura [1 ]
Tomoo Yamazaki [1 ]
Satoru Joshita [1 ]
Michiharu Komatsu [1 ]
Yoko Usami [4 ]
Kenji Sano [4 ]
Koji Igarashi [5 ]
Akihiro Matsumoto [1 ]
Eiji Tanaka [1 ]
机构
[1] Department of Internal Medicine,Division of Gastroenterology,Shinshu University School of Medicine
[2] Department of Metabolic Regulation,Shinshu University Graduate School of Medicine
[3] Research Center for Agricultural Food Industry,Shinshu University
[4] Department of Laboratory Medicine,Shinshu University Hospital
[5] Bioscience Division,TOSOH Corporation
关键词
Autotaxin; Non-alcoholic fatty liver disease; Fibrosis; Ballooning;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
AIM To examine the relationship between serum autotaxin(ATX) concentrations and clinicopathological findings in non-alcoholic fatty liver disease(NAFLD) patients.METHODS One hundred eighty-six NAFLD patients who had undergone liver biopsy between 2008 and 2017 were retrospectively enrolled.Serum samples were collected at the time of biopsy and ATX was measured by enzyme immunoassays.Sera obtained from 160 healthy,nonobese individuals were used as controls.Histological findings were graded according to an NAFLD scoring system and correlations with serum ATX were calculated by Spearman’s test.Diagnostic accuracy was evaluated using the area under the receiver operating characteristic curve(AUC).Cut-off values were identified by the Youden index,and the nearest clinically applicable value to the cutoff was considered the optimal threshold for clinical convenience.RESULTS Serum ATX levels were significantly higher in NAFLD patients than in controls(0.86 mg/L vs 0.76 mg/L,P < 0.001) and correlated significantly with ballooning score and fibrosis stage(r = 0.36,P < 0.001 and r = 0.45,P < 0.001,respectively).Such tendencies were stronger in female patients.There were no remarkable relationships between ATX and serum alanine aminotransferase,lipid profiles,or steatosis scores.The AUC values of ATX for predicting the presence of fibrosis(≥ F1),significant fibrosis(≥ F2),severe fibrosis(≥ F3),and cirrhosis(F4),were all more than 0.70 in respective analyses.CONCLUSION Serum ATX levels may at least partially reflect histological severity in NAFLD.
引用
收藏
页码:1239 / 1249
页数:11
相关论文
共 50 条
  • [1] Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
    Fujimori, Naoyuki
    Umemura, Takeji
    Kimura, Takefumi
    Tanaka, Naoki
    Sugiura, Ayumi
    Yamazaki, Tomoo
    Joshita, Satoru
    Komatsu, Michiharu
    Usami, Yoko
    Sano, Kenji
    Igarashi, Koji
    Matsumoto, Akihiro
    Tanaka, Eiji
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (11) : 1239 - 1249
  • [2] Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
    Honda, Yasushi
    Imajo, Kento
    Kobayashi, Takashi
    Kessoku, Takaomi
    Ogawa, Yuji
    Tomeno, Wataru
    Yoneda, Masato
    Kobayashi, Noritoshi
    Saito, Satoru
    Nakajima, Atsushi
    HEPATOLOGY RESEARCH, 2019, 49 (10) : 1136 - 1146
  • [3] Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease
    Sanyal, Arun J.
    Williams, Stephen A.
    Lavine, Joel E.
    Neuschwander-Tetri, Brent A.
    Alexander, Leigh
    Ostroff, Rachel
    Biegel, Hannah
    Kowdley, Kris V.
    Chalasani, Naga
    Dasarathy, Srinivasan
    Diehl, Anna Mae
    Loomba, Rohit
    Hameed, Bilal
    Behling, Cynthia
    Kleiner, David E.
    Karpen, Saul J.
    Williams, Jessica
    Jia, Yi
    Yates, Katherine P.
    Tonascia, James
    JOURNAL OF HEPATOLOGY, 2023, 78 (04) : 693 - 703
  • [4] Serum adiponectin levels and the severity of hepatic fibrosis in non alcoholic fatty liver disease patients
    Indrarti, Fahmi
    Ratnasari, Neneng
    Sinorita, Hemi
    Purnama, Putut Bayu
    Maduseno, Sutanto
    Triwikatmani, Catharina
    Nurdjanah, Siti
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 189 - 189
  • [5] Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease
    McPherson, Stuart
    Henderson, Elsbeth
    Burt, Alastair D.
    Day, Christopher P.
    Anstee, Quentin M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (05) : 1055 - 1062
  • [6] Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease
    Miyaaki, Hisamitsu
    Ichikawa, Tatsuki
    Kamo, Yasuhiro
    Taura, Naota
    Honda, Takuya
    Shibata, Hidetaka
    Milazzo, Maddalena
    Fornari, Francesca
    Gramantieri, Laura
    Bolondi, Luigi
    Nakao, Kazuhiko
    LIVER INTERNATIONAL, 2014, 34 (07) : E302 - E307
  • [7] Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease
    Iwadare, Takanobu
    Kimura, Takefumi
    Okumura, Taiki
    Wakabayashi, Shun-ichi
    Nakajima, Taro
    Kondo, Shohei
    Kobayashi, Hiroyuki
    Yamashita, Yuki
    Sugiura, Ayumi
    Fujimori, Naoyuki
    Yamazaki, Tomoo
    Kunimoto, Hideo
    Shimamoto, Satoshi
    Igarashi, Koji
    Joshita, Satoru
    Tanaka, Naoki
    Umemura, Takeji
    COMMUNICATIONS MEDICINE, 2024, 4 (01):
  • [8] Serum immunoglobulin A levels and non-alcoholic fatty liver disease
    Elias, Evan
    Uhanova, Julia
    Li, Qian
    Zhang, Manna
    Minuk, Gerald
    CANADIAN LIVER JOURNAL, 2018, 1 (04): : 248 - 255
  • [9] Serum Dehydroepiandrosterone Sulphate Levels in Patients with Non-Alcoholic Fatty Liver Disease
    Koga, Masafumi
    Saito, Hiroshi
    Mukai, Mikio
    Saibara, Toshiji
    Kasayama, Soji
    INTERNAL MEDICINE, 2011, 50 (16) : 1657 - 1661
  • [10] Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
    Chhabra, Sandeep
    Singh, Arshdeep
    Mehta, Varun
    Kaur, Amninder
    Bansal, Namita
    Sood, Ajit
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 409 - 416